Literature DB >> 33838021

Anterior-segment optical coherence tomography of filtering blebs in the early postoperative period of ab externo SIBS microshunt implantation with mitomycin C: Morphological analysis and correlation with intraocular pressure reduction.

Marta Ibarz Barberá1,2, Laura Morales Fernández3,4, Pedro Tañá Rivero5, Rosario Gómez de Liaño3, Miguel A Teus3,6,7,8.   

Abstract

PURPOSE: To analyse the morphological evolution of filtering blebs with anterior-segment OCT (AS-OCT) and its correlation with intraocular pressure after ab externo SIBS microshunt implantation with mitomycin C (MMC) during a 3-month follow-up period.
METHODS: Twenty-eight filtering blebs of 28 patients with open-angle glaucoma were measured horizontally and vertically in the sub-Tenon space with AS-OCT after ab externo SIBS microshunt implantation with MMC. The intraocular pressure (IOP) was monitored simultaneously at each visit. Maturation of and morphological changes in the blebs and correlations with the IOP were recorded.
RESULTS: The average median preoperative IOP of 20.7 (range, 12-30) mmHg decreased to 8.5 (range, 4-17), 8.9 (range, 5-17), 10.4 (range, 8-16) and 10.9 (range, 9-15) mmHg at 24 hr, 1 week, 1 month and 3 months, respectively (p < 0.001). A multiform morphology on AS-OCT prevailed at all time points, with a 3.5% rate of a uniform bleb morphology at the first week. The horizontal and vertical diameters of the blebs increased from baseline to the third month. The horizontal expansion (406 ± 127 μm on day 7, p = 0.04, 712 ± 211 μm on day 30, p = 0.02 and 952 ± 218 μm on day 90, p < 0.001) was greater than the vertical expansion (16 ± 18 μm, p = 0.3 on day 1, 63 ± 27 μm, p = 0.02 on day 30 and 137 ± 34 μm, p < 0.001 on day 90) without correlation with the IOP (r = -0.3, p = 0.2).
CONCLUSION: Anterior-segment OCT (AS-OCT) of the filtering blebs formed after ab externo SIBS microshunt implantation showed progressive horizontal and vertical expansion of the blebs in the sub-Tenon space, with a significant peak at the first month not significantly correlated with the decrease in the IOP.
© 2021 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  AS-OCT; Bleb; IOP; MIGS; POAG; PRESERFLO; glaucoma; mitomycin C

Mesh:

Substances:

Year:  2021        PMID: 33838021     DOI: 10.1111/aos.14863

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

1.  Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.

Authors:  Marta Ibarz Barberá; Fátima Martínez-Galdón; Elena Caballero-Magro; Marta Rodríguez-Piñero; Pedro Tañá-Rivero
Journal:  J Glaucoma       Date:  2022-05-17       Impact factor: 2.290

2.  Anterior Segment-Optical Coherence Tomography Bleb Morphology Comparison in Minimally Invasive Glaucoma Surgery: XEN Gel Stent vs. PreserFlo MicroShunt.

Authors:  Gloria Gambini; Matteo Mario Carlà; Federico Giannuzzi; Francesco Boselli; Giulia Grieco; Tomaso Caporossi; Umberto De Vico; Alfonso Savastano; Antonio Baldascino; Clara Rizzo; Raphael Kilian; Aldo Caporossi; Stanislao Rizzo
Journal:  Diagnostics (Basel)       Date:  2022-05-17

3.  Corneal Endothelial Cell Loss After PRESERFLO™ MicroShunt Implantation in the Anterior Chamber: Anterior Segment OCT Tube Location as a Risk Factor.

Authors:  Marta Ibarz-Barberá; Laura Morales-Fernández; Arturo Corroto-Cuadrado; Fátima Martinez-Galdón; Pedro Tañá-Rivero; Rosario Gómez de Liaño; Miguel A Teus
Journal:  Ophthalmol Ther       Date:  2021-11-26

4.  Evaluation of the Ultrastructural and In Vitro Flow Properties of the PRESERFLO MicroShunt.

Authors:  Marta Ibarz Barberá; Jose Luis Hernández-Verdejo; Jean Bragard; Javier Burguete; Laura Morales Fernández; Pedro Tañá Rivero; Rosario Gómez de Liaño; Miguel A Teus
Journal:  Transl Vis Sci Technol       Date:  2021-11-01       Impact factor: 3.283

Review 5.  PreserFlo® MicroShunt: An Overview of This Minimally Invasive Device for Open-Angle Glaucoma.

Authors:  Gloria Gambini; Matteo Mario Carlà; Federico Giannuzzi; Tomaso Caporossi; Umberto De Vico; Alfonso Savastano; Antonio Baldascino; Clara Rizzo; Raphael Kilian; Aldo Caporossi; Stanislao Rizzo
Journal:  Vision (Basel)       Date:  2022-02-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.